Back to All Agencies

RAPP Worldwide | Agency Profile, Contacts, AOR, Client Relationships


Service: crm, direct marketing

Main Telephone
(212) 209-1719
Primary Address
220 East 42nd Street
15th Floor
New York, NY 10017
USA

RAPP Worldwide Contacts

Contacts (5/8)
Name Title State
Devin O. Global Chief Diversity, Equity, Inclusion & Communications Officer NY
Sample of Related Brands
***********
Email: *****@*******.***
Main Phone: (212) 209-1719
Direct Phone: *** **** ***   ext: ****
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: 220 East 42nd Street
15th Floor
New York, NY
10017
USA
Steve T. Chief Financial Officer - Global NY
Marco S. Chief Executive Officer - Global NY
Shari R. Regional President, East NY
Jennifer C. Director, Program Management NY

Client Relationships

Current Past

Brand Service From To Media Spend
******* **************, ***. Digital *
******** ********, ***. Shopper, Experiential *
******** Creative *
****** **** ***** Digital *
****** ********* Digital *

See Winmo sales intelligence in action

WinmoEdge

Healthcare B2B Opps: Johnson & Johnson shifts focus to pharma, MedTech (Score 70)


Sales Lead: As it prepares to spin off its consumer health business in 2023,

  • Per execs in a recent earnings call, the company's consumer health only accounted for 16% of Q3 revenue, though in the US, sales rose 21.1%.
  • By the end of 2025, J&J's goal is for pharmaceuticals to individually be a $60b business.
  • Post-Covid growth has primarily come from areas such as diagnostic procedures and colonoscopies as well as surgical procedures.
    • J&J's key MedTech players during Q3 included the general surgery sector's wound closure products, the vision sector's contact lenses, and the orthopedics sector's trauma products.
    • Note: While the company will, of course, focus on these products, J&J's consumer business is also still advertising its medicine brands to customers.
  • As I briefly mentioned, J&J is in the process of separating from its consumer-oriented business.
    • The process will probably take 18-24 months.
    • The standalone firm will be called Kenvue.
  • The company will likely:
    • Continue increasing digital spend for its consumer business (more below) until the two split
    • Ramp up spend for its B2B business under a new DM (more below)
    • Seek new agency partners to support upcoming pharmaceutical- and MedTech-related initiatives
  • Target demographic:
    • J&J is primarily targeting medical organizations such as hospitals and doctors' offices.
    • However, since it hasn't yet split off from its consumer goods segment, the company is also still targeting potential and existing customers.
      • When it comes to consumers, J&J is primarily targeting Gen-Z and millennials via digital/paid social advertising.

​​​​​​Recent leadership shifts:

Additional spending insights (Note: Data is only available for J&J's consumer-oriented business):

  • Broadcast insights: Refer here for information regarding top brands' recent national TV spend.
  • Digital and social insights (digital ad spend, effectiveness, impressions, and performance)
    • YTD spend: Since the beginning of 2022, J&J has spent roughly $183.2m on digital ads, up % from the roughly $129.8m spent by this point last year.
    • YTD data: The company has earned around 22.3m digital impressions YTD via Facebook (46%), Instagram (43%), desktop video (9%), desktop display (2%), and Twitter (1%) ads.
    • Last year: In 2021, J&J spent approximately $188.2m on this channel, up % from the approximately $112.6m spent in 2020.
  • Additional channel insights  
    • The company also invests in print, radio, OOH, and local broadcast.
    • As you can tell, J&J's MedTech business also utilizes cause marketing via various social impact initiatives.

Additional agency insights:

Insight Sources: Broadcast insights estimated by Kantar.